Huron Consulting Group (HURN) Q2 2026 earnings summary

Executive summary

• Achieved record Q2 2026 revenues before reimbursable expenses (RBR) of $465.6M, up 15.7% year-over-year, with strong organic growth across all segments and capabilities.

• Net income rose 60.8% to $31.2M in Q2 2026, with diluted EPS up 75.2% to $1.91, aided by higher operating income and share repurchases.

• Adjusted EBITDA for Q2 2026 was $72.6M (15.6% of RBR), up 19.9% year-over-year; adjusted diluted EPS was $2.46, up 30.2%.

• AI-driven demand is fueling digital services growth, with over 60% of digital bookings in H1 2026 involving AI, up from 35% in H1 2025.

• Returned $53.1M to shareholders in Q2 and $208.6M year-to-date via share repurchases.

Financial highlights

• Q2 2026 RBR: $465.6M, up 15.7% from Q2 2025; organic RBR growth was 10.8%.

• Net income: $31.2M ($1.91/diluted share), up from $19.4M ($1.09/diluted share) in Q2 2025.

• Adjusted EBITDA: $72.6M (15.6% of RBR), up from $60.6M (15.1% of RBR) in Q2 2025.

• Adjusted EPS: $2.46, up 30.2% year-over-year.

• Cash flow from operations: $120.5M; free cash flow: $111.3M.

Outlook and guidance

• Increased full-year 2026 RBR guidance to $1.85B–$1.89B, up 12% at midpoint over 2025.

• Maintained adjusted EBITDA margin guidance at 14.5%–15% of RBR; adjusted EPS guidance raised to $9–$9.40, up 17% at midpoint.

• Healthcare RBR growth expected in mid-teens %, Education in mid to upper single digits, Commercial in low teens.

• Medium-term targets: low double-digit annual RBR growth, adjusted EBITDA margin expansion to 15–17% by 2029, and doubling adjusted diluted EPS from 2024 to 2029.

• RelateCare expected to add ~$30M RBR and be accretive to EPS by $0.10 in 2026.